Extending the Sunshine Act From Physicians to Patient Advocacy Organizations

Affiliations

¹ Genevieve P. Kanter is with the Division of General Internal Medicine, Department of Medicine, and Department of Medical Ethics & Health Policy, Perelman School of Medicine, and the Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.

Editorial

Genevieve P Kanter. Am J Public Health. 2018 Aug.

. 2018 Aug;108(8):978-979.

doi: 10.2105/AJPH.2018.304520.

¹ Genevieve P. Kanter is with the Division of General Internal Medicine, Department of Medicine, and Department of Medical Ethics & Health Policy, Perelman School of Medicine, and the Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.

No abstract available

Comment on

Industry Support of Patient Advocacy Organizations: The Case for an Extension of the Sunshine Act Provisions of the Affordable Care Act.
McCoy MS. McCoy MS. Am J Public Health. 2018 Aug;108(8):1026-1030. doi: 10.2105/AJPH.2018.304467. Epub 2018 Jun 21. Am J Public Health. 2018. PMID: 29927655 Free PMC article.

1. Patient Protection and Affordable Care Act. Pub L No. 111-148, 124 Stat. 855 (March 2010). Available at: https://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf. Accessed April 25, 2018.
1. Centers for Medicare and Medicaid Services. Open Payments. Available at: https://www.cms.gov/OpenPayments/index.html. Accessed April 25, 2018.
1. Centers for Medicare and Medicaid Services (CMS), HHS. Medicare, Medicaid, Children’s Health Insurance Programs; transparency reports and reporting of physician ownership or investment interests: final rule. Fed Regist. 2013;78(27):9457–9528. - PubMed
1. Kopp E, Lupkin S, Lucas E. Patient advocacy groups take in millions from drugmakers: is there a payback? Kaiser Health News. April 6, 2018. Available at: https://khn.org/news/patient-advocacy-groups-take-in-millions-from-drugm.... Accessed April 25, 2018.
1. US Senate Committee on Homeland Security and Governmental Affairs. Fueling an epidemic, report two: exposing the financial ties between opioid manufacturers and third party advocacy groups. February 12, 2018. Available at: https://www.hsdl.org/?abstract&did=808171. Accessed April 25, 2018.